For instance, incorporating urinary PAEs metabolite testing (e.g., MEHP, MnBP) into preoperative evaluations and postoperative follow-ups for PCa patients, combined with PSA levels and Gleason scores, can dynamically adjust treatment plans. Here, KLK3 is linked to posterior cortical atrophy.